XTL Biopharmaceuticals logo

XTL BiopharmaceuticalsNASDAQ: XTLB

Profile

Sector:

Healthcare

Industry:

Biotechnology

Country:

Israel

IPO:

01 September 2005

Next earnings report:

25 November 2024

Last dividends:

N/A

Next dividends:

N/A
$9.97 M
-43%vs. 3y high
18%vs. sector
-vs. 3y high
-vs. sector
-42%vs. 3y high
73%vs. sector
-vs. 3y high
-vs. sector

Price

regular market | Thu, 21 Nov 2024 21:00:00 GMT
$1.83+$0.06(+3.39%)

Dividend

No data over the past 3 years
No data over the past 3 years

Analysts recommendations

Institutional Ownership

What type of business is XTL Biopharmaceuticals?

XTL Biopharmaceuticals Ltd., a biopharmaceutical company, engages in the acquisition and development of pharmaceutical products for the treatment of autoimmune diseases in Israel. Its lead drug candidate is hCDR1, a Phase II-ready asset for the treatment of systemic lupus erythematosus and Sjogren's syndrome. It has a licensing agreement with Yeda Research and Development Company Limited for the research, development, and commercialization of hCDR1 for various indications. The company was formerly known as Xenograft Technologies Ltd. and changed its name to XTL Biopharmaceuticals Ltd. in July 1995. XTL Biopharmaceuticals Ltd. was incorporated in 1993 and is headquartered in Ramat Gan, Israel.

What sector is XTL Biopharmaceuticals in?

XTL Biopharmaceuticals is in the Healthcare sector

What industry is XTL Biopharmaceuticals in?

XTL Biopharmaceuticals is in the Biotechnology industry

What country is XTL Biopharmaceuticals from?

XTL Biopharmaceuticals is headquartered in Israel

When did XTL Biopharmaceuticals go public?

XTL Biopharmaceuticals initial public offering (IPO) was on 01 September 2005

What is XTL Biopharmaceuticals website?

https://www.xtlbio.com

Is XTL Biopharmaceuticals in the S&P 500?

No, XTL Biopharmaceuticals is not included in the S&P 500 index

Is XTL Biopharmaceuticals in the NASDAQ 100?

No, XTL Biopharmaceuticals is not included in the NASDAQ 100 index

Is XTL Biopharmaceuticals in the Dow Jones?

No, XTL Biopharmaceuticals is not included in the Dow Jones index

When was XTL Biopharmaceuticals the previous earnings report?

No data

When does XTL Biopharmaceuticals earnings report?

The next expected earnings date for XTL Biopharmaceuticals is 25 November 2024